as 06-05-2025 4:00pm EST
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | HOUSTON |
Market Cap: | 13.4M | IPO Year: | N/A |
Target Price: | $13.17 | AVG Volume (30 days): | 181.1K |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.34 | EPS Growth: | N/A |
52 Week Low/High: | $0.95 - $5.99 | Next Earning Date: | 05-15-2025 |
Revenue: | $5,696,123 | Revenue Growth: | 71.53% |
Revenue Growth (this year): | -59.78% | Revenue Growth (next year): | 11.28% |
MRKR Breaking Stock News: Dive into MRKR Ticker-Specific Updates for Smart Investing
GlobeNewswire
17 days ago
GlobeNewswire
18 days ago
Simply Wall St.
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
3 months ago
Argus Research
5 months ago
Argus Research
5 months ago
The information presented on this page, "MRKR Marker Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.